You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰恩康(301263.SZ):積極佈局衰老相關的研發項目,在研項目酒石酸卡巴拉汀膠囊已申報國家藥監局審批
格隆匯 10-18 19:33

格隆匯10月18日丨有投資者於投資者互動平台向泰恩康(301263.SZ)提問,“公司是否有養老用藥的儲備?”,公司回覆稱,公司積極佈局衰老相關的研發項目,在研項目酒石酸卡巴拉汀膠囊已申報國家藥監局審批,該藥主要用於治療輕、中度阿爾茨海默型痴呆(AD)的症狀,有效性已得到臨牀廣泛驗證;治療成人老花眼的鹽酸毛果芸香鹼滴眼液項目(HK067)目前已基本完成臨牀前相關工作,相關申報資料完備後將會盡快向國家藥審中心申報臨牀試驗申請;此外,公司在兩性健康領域、眼科領域、老年慢性病領域等研發立項了多個品種,詳細內容請參見公司《2022年年度報吿》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account